(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/buy_a_domain.png

Buy and register domain names online from CRWE Domains. Web hosting, spam-free email, web marketing, secure SSL Certificates and more

www.crwedomains.com

ad2

http://crweworld.com/assets/images/ad/ad4.png

Place Your Ad Here! Advertise your business online on CRWE WORLD. Your Company, product, or service in front of the world!

Contact Us: contact@crweworld.com

www.CRWEWorld.com

ad3

http://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

http://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com

ad5

http://crweworld.com/assets/images/ad/Pathology_Laboratories.png

Quest Diagnostics Inc. (NYSE:DGX) offers the most extensive clinical testing network in the U.S. The Company's extensive test menu includes routine biological testing; complex and specialized molecular and gene-based testing, and anatomic pathology testing. These services primarily help identify disease or risk factors for disease and predict and monitor response to treatment.

www.QuestDiagnostics.com






2 Result: CLBS

Caladrius Biosciences Subsidiary PCT, LLC Enters Into Global Collaboration and License Agreement with Hitachi Chemical

March 14th, 2016

Caladrius Sells 19.9% equity stake in PCT for $19.4 million Licenses cell therapy technology for certain Asian territories for $5.6 million and future royalties BASKING RIDGE, N.J. / CRWEPRESSRELEASE / March 14, 2016 — Caladrius Bios. Read more

Caladrius Announces Publication of Two-Year Results from Phase 1 Trial of Type 1 Diabetes Product Candidate in Science Translational Medicine

December 01st, 2015

Study demonstrated persistence of Tregs, safety and feasibility; supports upcoming Phase 2 study to test efficacy of the therapy Basking Ridge, NJ / CRWEPRESSRELEASE / December 1, 2015 – Caladrius Biosciences, Inc. (“Caladrius&rdq. Read more

Load More Content